Maxidex (Dexamethasone)

Maxidex, a glucocorticoid eye drop, targets inflammatory pathways in ocular disease. It is indicated for several eye conditions where inflammation control is essential.

• Post‑operative ocular inflammation: reduces swelling, pain and redness after eye surgery.
• Uveitis: suppresses intra‑ocular inflammation to preserve vision.
• Allergic conjunctivitis: alleviates itching, redness and swelling caused by allergens.
• Other inflammatory eye conditions: manages inflammation in conditions such as scleritis or keratitis.

• Dexamethasone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This action inhibits phospholipase A2, decreasing arachidonic acid release, and suppresses cytokine and prostaglandin synthesis, leading to reduced inflammatory cell infiltration and edema in ocular tissues.

Adverse reactions may occur with ocular corticosteroid use. Patients should be monitored for any new symptoms.

Common Side Effects

• Burning or stinging sensation upon instillation.
• Transient blurred vision.
• Increased intra‑ocular pressure (mild).
• Conjunctival hyperemia.
• Mild ocular irritation.

Serious or Rare Side Effects

• Significant elevation of intra‑ocular pressure leading to glaucoma.
• Cataract formation with prolonged use.
• Secondary ocular infection (bacterial, fungal, or viral).
• Delayed wound healing after ocular surgery.
• Hypersensitivity reactions such as severe eye swelling or rash.

Before using Maxidex, consider the following safety measures.

• Monitor intra‑ocular pressure: regular eye pressure checks are advised.
• Avoid use in active ocular infections: steroids can worsen infections.
• Use with caution in patients having a history of glaucoma or cataracts.
• Do not discontinue abruptly if used long‑term: taper under medical supervision.
• Pregnant or breastfeeding women: consult a healthcare professional before use.
• Store at room temperature: keep in the original container, protect from light and moisture.

Maxidex may interact with other ophthalmic agents or systemic drugs that affect intra‑ocular pressure.

Major Interactions (Avoid)

• Concurrent use of other topical corticosteroids: may increase risk of pressure elevation.
• Systemic carbonic anhydrase inhibitors (e.g., acetazolamide): can potentiate intra‑ocular pressure rise.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory eye drops: may alter anti‑inflammatory efficacy.
• Anticholinergic eye drops: could affect pupil size and ocular comfort.
• Systemic immunosuppressants: may enhance overall immunosuppression.
• Beta‑blocker eye drops: monitor for additive ocular hypotensive effects.